Evidence map›Paper›PMID 42036736›Full record

ReviewClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2026

Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations.

June Ho Chang, Yoo Jin Jang, Se Chang Yoon, Ji Hyun An, Jung-Seok Choi, Hong Jin Jeon

Abstract readReview
In one paragraph

Review in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

June Ho ChangDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8823-4394
Yoo Jin JangDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-9945-3541
Se Chang YoonDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0004-9731-8898
Ji Hyun AnDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1628-9617
Jung-Seok ChoiDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2139-0522
Hong Jin JeonDepartment of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6126-542X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Digital psychiatry has rapidly expanded with the integration of immersive technologies such as virtual reality (VR) and augmented reality (AR). These modalities allow for controlled, engaging, and ecologically valid interventions across a wide range of psychiatric disorders. In this review, a narrative synthesis was conducted based on systematic reviews, meta-analyses, and randomized controlled trials identified through PubMed, Google Scholar, complemented by seminal earlier works. VR-based therapies demonstrated robust efficacy for anxiety disorders and phobias, with meta-analytic evidence supporting large effect sizes. For post-traumatic stress disorder virtual reality exposure therapy was superior to waitlist control and comparable to established psychotherapies, although AR exposure therapy remains underexplored. In autism spectrum disorder, VR and AR interventions significantly enhanced cognitive, social, and communication skills. AR applications have additionally been validated for cognitive assessment in Alzheimer's disease, and VR/AR-supported rehabilitation showed promise in attention deficit hyperactivity disorder and neurodevelopmental disorders. Despite encouraging findings, challenges remain, including small sample sizes, short follow-up periods, heterogeneity of protocols, and risks such as cybersickness or fatigue. VR and AR represent innovative tools with growing empirical support across psychiatric practice, extending from diagnostic assessment to therapeutic and rehabilitative interventions. Standardized protocols, large-scale trials, and long-term outcome studies are needed to integrate these technologies into routine clinical care.

Indexed as

Anxiety disordersAugmented realityDigital healthPsychiatryVirtual reality

Identifiers

PMID42036736
PMCPMC13122160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.